Omicron fear has led to some of the best entry points ever to own particular growth companies. These nine are charged… and ready to surge:
Puma Biotech (PUMA) $122M
Viant (DSP) $570M
Perion (PERI) $840M
Vaxart (VXRT) $882M
PubMatic (PUBM) $1.88B
Magnite (MGNI) $2.22B
fuboTV (FUBO) $2.57B
DoubleVerify (DV) $4.76B
Trade Desk (TTD) $49.7B
“No free energy device will ever be allowed to reach the market.” -Nikola Tesla